Animal geneticist’s risks to be a cash cow, research shows


Just a few months after being not fed up, the top stud bull died in 2015. In the almost 15 years’ service for Genus, Shottle became the UK”s one of the first bulls to yield and sell more than one million doses of semen. He left a magnificent bequest of 100,000 daughters in dairy herds across to different countries, at least 22, – and a business establishment racing to fund on new technology.

Offering the best quality bull sperm to livestock producers, Genus reproduces and sells genetically higher-ranking pigs. Having billions of meat-eating mouths to feed, farmers are making most of their time operating at scale and are eager to enhance profitability and efficiency.

Aiming to be transformative in the long run, investor focus is shifting to the advances that the company is hoping to make. It is already escalating. Thus, Research and development expenditures rose by at least £6.2m to £21.9m in the mid-year.

By cutting and replacing strips of genetic code from an animal’s DNA, it is possible to reproduce disease-resistance herds that enhance outcomes. Thus, Gene editing has captivated the most attention of the many.

In using CRISPR-Cas9 technology in pig and cattle breeds, Genus has gone into an exclusive global agreement with US firm Caribou Biosciences. It made an official announcement that a project with the Roslin Institute had yielded pigs that may be secured from PRRS (Porcine Reproductive and Respiratory Syndrome), which results from dramatic breathing issues and breeding problems at a cost to the European pig industry of more than £1.3bn a year.